Asamli, Kaiser U.

HRN: 21-47-76  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/25/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/25/2022
07/31/2022
IV
4.5g
Q6h
Pleural Abscess, Sepsis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  PneumoniaBloodstreamUnspecified Sepsis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: